OCUL

Ocular Therapeutix (OCUL)

About Ocular Therapeutix (OCUL)

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Details

Daily high

$9.99

Daily low

$8.98

Price at open

$9.30

52 Week High

$11.31

52 Week Low

$2.00

Market cap

1.5B

Dividend yield

0.00%

Volume

1.6M

Avg. volume

1.3M

P/E ratio

-7.26

Ocular Therapeutix News